Laman UtamaORMP • NASDAQ
add
Oramed Pharmaceuticals, Inc.
Tutup sebelumnya
$2.30
Julat hari
$2.28 - $2.34
Julat tahun
$1.82 - $3.09
Permodalan pasaran
95.18J USD
Bilangan Purata
65.81K
Nisbah P/E
-
Hasil dividen
-
Pertukaran utama
NASDAQ
Berita pasaran
Invezz
2 hari lalu
Amaran risiko: ‘kemelesetan sederhana’ boleh menjejaskan tahap S&P 500 kepada 3,700
0.74%
Kewangan
Penyata Pendapatan
Hasil
Pendapatan bersih
| (USD) | Dis 2024info | Perubahan T/T |
|---|---|---|
Hasil | — | — |
Perbelanjaan pengendalian | 3.60J | -7.27% |
Pendapatan bersih | -10.19J | -176.40% |
Margin untung bersih | — | — |
Pendapatan bagi setiap syer | — | — |
EBITDA | -3.56J | 6.80% |
Kadar cukai berkesan | -4.25% | — |
Kunci Kira-kira
Jumlah aset
Jumlah liabiliti
| (USD) | Dis 2024info | Perubahan T/T |
|---|---|---|
Pelaburan tunai dan jangka pendek | 141.93J | -12.41% |
Jumlah aset | 155.28J | -29.60% |
Jumlah liabiliti | 9.93J | -82.78% |
Jumlah ekuiti | 145.35J | — |
Syer tertunggak | 40.85J | — |
Harga kepada buku | 0.63 | — |
Pulangan pada aset | -5.61% | — |
Pulangan pada modal | -5.96% | — |
Aliran Tunai
Perubahan bersih dalam tunai
| (USD) | Dis 2024info | Perubahan T/T |
|---|---|---|
Pendapatan bersih | -10.19J | -176.40% |
Tunai daripada operasi | -1.91J | -34.77% |
Tunai daripada pelaburan | 15.42J | -48.58% |
Tunai daripada pembiayaan | -1.20J | 95.22% |
Perubahan bersih dalam tunai | 12.32J | 243.35% |
Aliran tunai bebas | -1.38J | 39.15% |
Perihal
Oramed Pharmaceuticals Inc., is a publicly traded company engaged in the development of oral drug delivery systems – most notably an oral insulin capsule for treating type 2 diabetes. The company was founded in 2006 and is headquartered in Jerusalem. Its shares are listed on the NASDAQ Capital Market and the Tel Aviv Stock Exchange. Wikipedia
CEO
Diasaskan
2006
Tapak web
Pekerja
13
